Clinical Trial Update: Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating LDE225 (sonidegib) in combination with etoposide and cisplatin as first-line therapy for extensive-stage small cell lung cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• LDE225 (sonidegib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED